Clinical Trial Update: Understanding the Risk of Blood Clots and Bleeding in Patients With Hematological Malignancies, HAT Study

View source ↗

Summary

This completed clinical trial (NCT05053100) investigates the risk of blood clots and bleeding in patients with hematologic cancers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Deep Vein Thrombosis
• Hodgkin Lymphoma
• Leukemia
• Multiple Myeloma
• Myeloproliferative Neoplasm
• Non-hodgkin Lymphoma
• Thrombocytopenia

Snippet

Sponsor: Mayo Clinic | Conditions: Acute Leukemia, Deep Vein Thrombosis | Status: COMPLETED